Order Article Reprints

Quagliariello V, Berretta M, Bisceglia I, Iovine M, Barbato M, Arianna R, Canale ML, Paccone A, Inno A, Scherillo M, et al. PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition. International Journal of Molecular Sciences. 2025; 26(14):6617. https://doi.org/10.3390/ijms26146617

Quagliariello, Vincenzo, Massimiliano Berretta, Irma Bisceglia, Martina Iovine, Matteo Barbato, Raffaele Arianna, Maria Laura Canale, Andrea Paccone, Alessandro Inno, Marino Scherillo, and et al. 2025. "PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition" International Journal of Molecular Sciences 26, no. 14: 6617. https://doi.org/10.3390/ijms26146617

Quagliariello, V., Berretta, M., Bisceglia, I., Iovine, M., Barbato, M., Arianna, R., Canale, M. L., Paccone, A., Inno, A., Scherillo, M., Oliva, S., Cadeddu Dessalvi, C., Mauriello, A., Maurea, C., Fonderico, C., Maratea, A. C., Gabrielli, D., & Maurea, N. (2025). PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition. International Journal of Molecular Sciences, 26(14), 6617. https://doi.org/10.3390/ijms26146617